Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Poly Medicure Limited, commonly referred to as Poly Medicure, is a prominent Indian company specialising in the manufacturing of medical, precision, and optical instruments, as well as watches and clocks. Headquartered in India, the firm has established a strong presence across key regional markets, serving healthcare providers and industrial clients alike.
Founded in 1995, Poly Medicure has grown steadily, earning recognition for its high-quality medical devices and innovative product offerings. Its core product range includes syringes, IV sets, and other critical medical consumables, distinguished by stringent quality standards and technological advancements. The company's commitment to excellence has positioned it as a trusted name within the medical industry, with notable achievements in expanding its global footprint and maintaining a reputation for reliability and precision.
-13 vs industry average
Poly Medicure’s score of 19 is lower than 34% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Poly Medicure, headquartered in India and operating in the Medical, precision and optical instruments, watches and clocks industry, reported Scope 1 and 2 emissions for 2025. In 2025, the company's Scope 1 emissions were 3,602,580 kg CO2e, including 249,480 kg CO2e from mobile combustion, 963,290 kg CO2e from fugitive emissions, and 2,125,180 kg CO2e from stationary combustion. Scope 2 emissions, primarily from purchased electricity, totalled 40,088,730 kg CO2e. For 2024, Poly Medicure's Scope 1 emissions were 2,319,850 kg CO2e, with 284,540 kg CO2e from mobile combustion, 805,630 kg CO2e from fugitive emissions, and 1,229,680 kg CO2e from stationary combustion. Scope 2 emissions in 2024 were 33,962,280 kg CO2e from purchased electricity. The company also reported Scope 1 emissions of 2,319,850 kg CO2e and Scope 2 emissions of 33,962,280 kg CO2e in 2023. In 2022, Scope 1 emissions were 3,114,940 kg CO2e and Scope 2 emissions were 30,230,620 kg CO2e. Poly Medicure has not disclosed Scope 3 emissions data. The company has no publicly available reduction targets or climate pledges.
No climate goals have been disclosed for Poly Medicure yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more